Therapeutic Drug Monitoring Increasing IBD Treatment Efficacy
Infliximab, adalimumab and other tumour necrosis factor inhibitors have revolutionised the treatment of several immune mediated inflammatory diseases. Still, many patients do not respond sufficiently to therapy or lose efficacy over time. Therapeutic drug monitoring (TDM), an individualised treatment strategy based on systematic assessments of serum drug concentrations, has been proposed as a clinical tool to optimise efficacy of
treatment.
Modern Medicine – Issue 4 2020
